Democrats are suddenly eyeing a valuable pharma asset: its patents

Democrats are suddenly eyeing a valuable pharma asset: its patents

Source: 
Stat
snippet: 

Democrats, newly empowered in D.C. and on the hunt for bigger and bolder ways to lower drug prices, are suddenly taking aim at a far more central part of pharma’s monopoly power: the patents the industry holds on its drugs.